Crescent Biopharma Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: CBIO
Share price (4/10/26): $18.17
Market cap (4/10/26): $501 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 7 pages Plan of Conversion

from DEFA14A 108 pages Agreement and Plan of Merger and Reorganization Among: Glycomimetics, Inc. Gemini Merger Sub Corp.; Gemini Merger Sub II, LLC; and Crescent Biopharma, Inc. Dated as of October 28, 2024

from 8-K 108 pages Agreement and Plan of Merger and Reorganization Among: Glycomimetics, Inc. Gemini Merger Sub Corp.; Gemini Merger Sub II, LLC; and Crescent Biopharma, Inc. Dated as of October 28, 2024